Artemis Investment Management LLP Decreases Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Artemis Investment Management LLP trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 54.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,897 shares of the company's stock after selling 8,299 shares during the quarter. Artemis Investment Management LLP's holdings in HCA Healthcare were worth $2,383,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Congress Wealth Management LLC DE boosted its holdings in shares of HCA Healthcare by 3.4% in the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock worth $312,000 after buying an additional 34 shares during the last quarter. Evergreen Private Wealth LLC lifted its holdings in shares of HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock worth $3,838,000 after buying an additional 35 shares in the last quarter. Perigon Wealth Management LLC lifted its holdings in shares of HCA Healthcare by 2.3% in the first quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock worth $621,000 after buying an additional 40 shares in the last quarter. Whittier Trust Co. raised its stake in HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after purchasing an additional 41 shares in the last quarter. Finally, Barden Capital Management Inc. raised its stake in HCA Healthcare by 1.4% during the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock valued at $1,009,000 after purchasing an additional 41 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA Healthcare stock traded up $1.34 during trading on Friday, reaching $379.00. The company had a trading volume of 1,554,834 shares, compared to its average volume of 1,468,120. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. The firm's 50-day simple moving average is $366.55 and its 200 day simple moving average is $336.91. The firm has a market capitalization of $91.18 billion, a PE ratio of 16.85, a price-to-earnings-growth ratio of 1.31 and a beta of 1.49.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. HCA Healthcare's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm earned $5.36 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. The ex-dividend date is Monday, June 16th. HCA Healthcare's payout ratio is 12.81%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Guggenheim assumed coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Barclays set a $416.00 price target on shares of HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Wall Street Zen lowered shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research report on Friday. Finally, Morgan Stanley set a $410.00 price objective on shares of HCA Healthcare and gave the company an "equal weight" rating in a research report on Monday, June 9th. Eight equities research analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $395.71.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer now owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.